Aliénor Berges

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

Duncan Richards, Louise Cookson, Aliénor Berges et al. · New England Journal of Medicine · 2015 · 376 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study

Timothy A. Yap, Matthew Krebs, Sophie Postel‐Vinay et al. · Clinical Cancer Research · 2021 · 136 citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial

Vincent Meininger, Pierre-François Pradat, Andrea M. Corse et al. · PLoS ONE · 2014 · 87 citations · Full text

Pharmacy, Neurology, Pharmacology +17

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer

Seung Tae Kim, Simon A. Smith, Peter G. Mortimer et al. · Clinical Cancer Research · 2021 · 79 citations · Full text

Medicine, Oncology, Pharmacology +15